Clinical Trial

A Study to Evaluate the Safety and Pharmacokinetics of AD-231 Compared to Coadministration of AD-231A, AD-231D and AD-231C

Name: A Study to Evaluate the Safety and Pharmacokinetics of AD-231 Compared to Coadministration of AD-231A, AD-231D and AD-231C — clinical trial record (NCT07590167)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated May 15, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.

Summary

A Study to Evaluate the Safety and Pharmacokinetics of AD-231 Compared to Coadministration of AD-231A, AD-231D and AD-231C

Trial Details

NCT Number	NCT07590167
Lead Sponsor	Addpharma Inc.
Conditions	Dyslipidemia, Hypertension
Enrollment	60 participants
Start Date	2026-06
Primary Completion	2026-07 (estimated)
Study Completion	2026-07 (estimated)
Updated on ClinicalTrials.gov	2026-05-15